| Chemistry Chapter 3 |
Chemistry Unit 1 |
Unfinished |
2024-08-13 |
Wasurenboh |
17 |
0 |
edit |
|
| Chemistry Chapter 2 |
Chemistry Chapter 2 |
Unfinished |
2023-10-15 |
Wasurenboh |
32 |
0 |
edit |
|
| Compound Prefixes |
|
Unfinished |
2023-11-08 |
Wasurenboh |
10 |
0 |
edit |
|
| Gas Laws |
Gas Laws |
Unfinished |
2024-03-02 |
Wasurenboh |
9 |
0 |
edit |
|
| Poly Atomic Ions |
Poly Atomic Ions |
Unfinished |
2024-03-05 |
Wasurenboh |
20 |
0 |
edit |
|
| Denat and Types |
|
Unfinished |
2024-04-09 |
Wasurenboh |
13 |
0 |
edit |
|
| Orgo Compound |
Orgo Compound |
Unfinished |
2024-08-13 |
Wasurenboh |
22 |
0 |
edit |
|
| Microbe Control 1 |
Microbe Control 1 |
Unfinished |
2024-09-24 |
Wasurenboh |
20 |
0 |
edit |
|
| Anat 1 - Ch. 1 |
Introduction |
Unfinished |
2024-06-19 |
Wasurenboh |
13 |
0 |
edit |
|
| Anat Cha 1 parts |
Anat Cha 1 parts |
Unfinished |
2024-06-17 |
Wasurenboh |
20 |
0 |
edit |
|
| Anterior Landmarks |
Anatomical Parts I |
Unfinished |
2024-06-21 |
Wasurenboh |
20 |
0 |
edit |
|
| Dorsal Landmarks |
Dorsal Landmarks |
Unfinished |
2024-06-19 |
Wasurenboh |
17 |
0 |
edit |
|
| Cell Structures |
Cell Part 1 |
Unfinished |
2024-06-25 |
Wasurenboh |
21 |
0 |
edit |
|
| Cell Diffusion+Life |
Cell Diffusion+Life |
Unfinished |
2024-06-23 |
Wasurenboh |
24 |
0 |
edit |
|
| Epi Tissues 1 |
Tissues 1 |
Unfinished |
2024-06-24 |
Wasurenboh |
20 |
0 |
edit |
|
| Connective Tissue |
Connective Tissue |
Unfinished |
2024-06-24 |
Wasurenboh |
20 |
0 |
edit |
|
| Membrane+Repair |
Membrane+Repair |
Unfinished |
2024-06-24 |
Wasurenboh |
16 |
0 |
edit |
|
| Anatomical Landmarks |
Anatomical Landmarks |
Unfinished |
2024-06-25 |
Wasurenboh |
17 |
0 |
edit |
|
| Integumentary Sys |
Integumentary Sys |
Unfinished |
2024-06-26 |
Wasurenboh |
13 |
0 |
edit |
|
| Osseous Tissues |
Osseous Tissues |
Unfinished |
2024-07-06 |
Wasurenboh |
20 |
0 |
edit |
|
| Osseous Functions |
Osseous Functions |
Unfinished |
2024-07-05 |
Wasurenboh |
21 |
0 |
edit |
|
| Axial Skeleton |
Axial Skeleton |
Unfinished |
2024-07-05 |
Wasurenboh |
21 |
0 |
edit |
|
| Appen skelly & Carti |
Appendicular skelly |
Unfinished |
2024-07-08 |
Wasurenboh |
20 |
0 |
edit |
|
| Names of Bone Marks |
Names of Bone Marks |
Unfinished |
2024-07-08 |
Wasurenboh |
18 |
0 |
edit |
|
| Muscle I - OIF |
Muscle I - OIF |
Unfinished |
2024-07-13 |
Wasurenboh |
20 |
0 |
edit |
|
| Muscles 2 - IOF |
Muscles 2 - IOF |
Unfinished |
2024-07-13 |
Wasurenboh |
20 |
0 |
edit |
|
| NueroSkeletal 1 |
NeuroSkeletal 1 |
Unfinished |
2024-07-19 |
Wasurenboh |
20 |
0 |
edit |
|
| Neuroskeletal 2 |
|
Unfinished |
2024-07-19 |
Wasurenboh |
20 |
0 |
edit |
|
| Senses |
Senses |
Unfinished |
2024-07-24 |
Wasurenboh |
26 |
0 |
edit |
|
| Cranial Nerves |
Cranial Nerves |
Unfinished |
2024-07-24 |
Wasurenboh |
12 |
0 |
edit |
|
| Life Sci 1 |
Life Sci 1 |
Unfinished |
2024-08-12 |
Wasurenboh |
19 |
0 |
edit |
|
| Life Sci 2 |
Life Sci 2 |
Unfinished |
2024-08-14 |
Wasurenboh |
19 |
0 |
edit |
|
| Endocrine System |
Endocrine System |
Unfinished |
2024-10-02 |
Wasurenboh |
21 |
0 |
edit |
|
| Microbio Ch. 4 |
Microbio Ch. 4 |
Unfinished |
2024-09-18 |
Wasurenboh |
20 |
0 |
edit |
|
| Blood |
Blood |
Unfinished |
2024-10-02 |
Wasurenboh |
20 |
0 |
edit |
|
| Metabolism |
Metabolism |
Unfinished |
2024-09-16 |
Wasurenboh |
21 |
0 |
edit |
|
| Metabolism II |
Metabolism II |
Unfinished |
2024-09-24 |
Wasurenboh |
19 |
0 |
edit |
|
| Leukocyte IDs |
Leukocyte IDs |
Unfinished |
2024-09-18 |
Wasurenboh |
9 |
0 |
edit |
|
| Microbio Ch 6 |
Microbio Ch 6 |
Unfinished |
2024-09-20 |
Wasurenboh |
32 |
0 |
edit |
|
| Microbial Growth |
Microbal Growth |
Unfinished |
2024-09-21 |
Wasurenboh |
21 |
0 |
edit |
|
| Microbe Diversity |
Microbe Diversity |
Unfinished |
2024-09-24 |
Wasurenboh |
8 |
0 |
edit |
|
| Cha 4&5 Extras I |
Cha 4&5 Extras I |
Unfinished |
2024-09-24 |
Wasurenboh |
20 |
0 |
edit |
|
| Extras Ch 5 & 6 |
Extras Ch 5 & 6 |
Unfinished |
2024-09-24 |
Wasurenboh |
15 |
0 |
edit |
|
| The Heart |
The Heart |
Unfinished |
2024-10-02 |
Wasurenboh |
20 |
0 |
edit |
|
| Heart Pt. 2 |
Heart Pt. 2 |
Unfinished |
2024-10-02 |
Wasurenboh |
20 |
0 |
edit |
|
| Blood Vessels |
Blood Vessels |
Unfinished |
2024-10-02 |
Wasurenboh |
20 |
0 |
edit |
|
| Blood Vessels II |
Blood Vessels II |
Unfinished |
2024-10-02 |
Wasurenboh |
18 |
0 |
edit |
|
| Microbial Pathogenic |
Microbial Pathogenic |
Unfinished |
2024-10-17 |
Wasurenboh |
21 |
0 |
edit |
|
| Heart Sounds&Errata |
Heart Sounds&Errata |
Unfinished |
2024-10-02 |
Wasurenboh |
16 |
0 |
edit |
|
| AP II Test Cram |
AP II Test Cram |
Unfinished |
2024-10-03 |
Wasurenboh |
7 |
0 |
edit |
|
| Lymphatic System |
Lymphatic System |
Unfinished |
2024-10-17 |
Wasurenboh |
21 |
0 |
edit |
|
| Urinary System |
Urinary System |
Unfinished |
2024-10-29 |
Wasurenboh |
20 |
0 |
edit |
|
| Lymph System 2 |
Lymph System 2 |
Unfinished |
2024-10-17 |
Wasurenboh |
7 |
0 |
edit |
|
| 12.2 Qs |
12.2 Qs |
Unfinished |
2024-10-18 |
Wasurenboh |
15 |
0 |
edit |
|
| 15.1 |
15.1 |
Unfinished |
2024-10-22 |
Wasurenboh |
20 |
0 |
edit |
|
| 15.2 |
15.2 |
Unfinished |
2024-10-22 |
Wasurenboh |
13 |
0 |
edit |
|
| Urinary Sys II |
Urinary Sys II |
Unfinished |
2024-10-29 |
Wasurenboh |
19 |
0 |
edit |
|
| Respiratory System |
Respiratory System |
Unfinished |
2024-11-01 |
Wasurenboh |
20 |
0 |
edit |
|
| Respiratory Sys II |
Respiratory Sys II |
Unfinished |
2024-11-01 |
Wasurenboh |
17 |
0 |
edit |
|
| Digestive Sys I |
Digestive Sys I |
Unfinished |
2024-11-01 |
Wasurenboh |
19 |
0 |
edit |
|
| MCB Chap 13 |
MCB Chap 13 |
Unfinished |
2024-11-20 |
Wasurenboh |
20 |
0 |
edit |
|
| 13.2 |
13.2 |
Unfinished |
2024-11-12 |
Wasurenboh |
18 |
0 |
edit |
|
| 17.1 |
17.1 |
Unfinished |
2024-11-19 |
Wasurenboh |
20 |
0 |
edit |
|
| 17.2 |
17.2 |
Unfinished |
2024-11-12 |
Wasurenboh |
20 |
0 |
edit |
|
| Extra Test 2.1 |
Extra Test 2.1 |
Unfinished |
2024-11-26 |
Wasurenboh |
17 |
0 |
edit |
|
| Urinary Sys Misc. |
Urinary Sys III |
Unfinished |
2024-11-14 |
Wasurenboh |
15 |
0 |
edit |
|
| DigeSys II |
DigeSys II |
Unfinished |
2024-11-18 |
Wasurenboh |
20 |
0 |
edit |
|
| 19.1 |
19.1 |
Unfinished |
2024-11-23 |
Wasurenboh |
20 |
0 |
edit |
|
| 21.1 |
21.1 |
Unfinished |
2024-11-26 |
Wasurenboh |
20 |
0 |
edit |
|
| 21.2 |
21.2 |
Unfinished |
2024-11-26 |
Wasurenboh |
18 |
0 |
edit |
|
| Immuno Qs |
Immuno Qs |
Unfinished |
2024-11-26 |
Wasurenboh |
7 |
0 |
edit |
|
| 22.1 |
22.1 |
Unfinished |
2024-11-30 |
Wasurenboh |
20 |
0 |
edit |
|
| 22.2 |
22.2 |
Unfinished |
2024-11-30 |
Wasurenboh |
20 |
0 |
edit |
|
| 23.1 |
23.1 |
Unfinished |
2024-11-30 |
Wasurenboh |
20 |
0 |
edit |
|
| 24.1 |
24.1 |
Unfinished |
2024-12-02 |
Wasurenboh |
20 |
0 |
edit |
|
| 24.2 |
24.2 |
Unfinished |
2024-12-02 |
Wasurenboh |
19 |
0 |
edit |
|
| 25.1 |
25.1 |
Unfinished |
2024-12-02 |
Wasurenboh |
20 |
0 |
edit |
|
| 25.2 |
25.2 |
Unfinished |
2024-12-02 |
Wasurenboh |
20 |
0 |
edit |
|
| 26.2 |
26.2 |
Unfinished |
2024-12-06 |
Wasurenboh |
13 |
0 |
edit |
|
| Osteoporosis |
Osteoporosis |
Unfinished |
2025-12-15 |
Wasurenboh |
17 |
0 |
edit |
|
| Pharm Ch 3.2 |
Pharmacokinetics and P. Dynamics |
Unfinished |
2024-12-18 |
Wasurenboh |
20 |
0 |
edit |
|
| Pharma Ch 3.1 |
Pharmacokinetics and P. Dynamics |
Unfinished |
2024-12-18 |
Wasurenboh |
20 |
0 |
edit |
|
| Pharm Ch 3.3 |
Pharmacokinetics and P. Dynamics |
Unfinished |
2024-12-18 |
Wasurenboh |
19 |
0 |
edit |
|
| Pharm Ch 4.1 |
Pharmacogenetics |
Unfinished |
2024-12-18 |
Wasurenboh |
15 |
0 |
edit |
|
| Pharm Ch 1.1 |
Clinical Judgment and Nursing Process |
Unfinished |
2024-12-18 |
Wasurenboh |
14 |
0 |
edit |
|
| Pharm Ch 2.1 |
Drug Developoment and Ethics |
Unfinished |
2024-12-18 |
Wasurenboh |
21 |
0 |
edit |
|
| Pharm 2.2 |
Federal Legilations |
Unfinished |
2024-12-18 |
Wasurenboh |
18 |
0 |
edit |
|
| Pharm Ch. 9 |
Safety and Quality |
Unfinished |
2024-12-23 |
Wasurenboh |
20 |
0 |
edit |
|
| Pharm Ch.12.1 |
Fluids and Electrolytes |
Unfinished |
2024-12-30 |
Wasurenboh |
20 |
0 |
edit |
|
| Pharm Ch 12.2 |
Fluids and Electrolytes |
Unfinished |
2024-12-30 |
Wasurenboh |
19 |
0 |
edit |
|
| Pharm Terms |
Pharm Terms |
Unfinished |
2025-01-08 |
Wasurenboh |
20 |
0 |
edit |
|
| Pharm Ch 11 |
Drug Calculations |
Unfinished |
2025-01-08 |
Wasurenboh |
16 |
0 |
edit |
|
| Diabetes Meds 1 |
Sulfonylureas & Meglitinides |
Unfinished |
2025-01-18 |
Wasurenboh |
18 |
0 |
edit |
|
| Diabetes Meds 2 |
Biguanides and Thiazolidinediones |
Unfinished |
2025-01-18 |
Wasurenboh |
19 |
0 |
edit |
|
| Diabetes Meds 3 |
Alpha-Glucose DPP-4 Inhibitors |
Unfinished |
2025-01-18 |
Wasurenboh |
16 |
0 |
edit |
|
| Diabetes insulin |
Insulin |
Unfinished |
2025-01-18 |
Wasurenboh |
17 |
0 |
edit |
|
| Diabetes Meds 6 |
Amylin and Incretin |
Unfinished |
2025-01-18 |
Wasurenboh |
19 |
0 |
edit |
|
| Diabetes Meds 7 |
Hyperglycemics and General |
Unfinished |
2025-01-18 |
Wasurenboh |
20 |
0 |
edit |
|
| Oral Med General |
Pharm |
Unfinished |
2025-01-19 |
Wasurenboh |
17 |
0 |
edit |
|
| Pharm Test 1 |
Pharm Test 1 |
Unfinished |
2025-01-27 |
Wasurenboh |
20 |
0 |
edit |
|
| Pharm Test 1.2 |
Pharm Test 1.2 |
Unfinished |
2025-01-27 |
Wasurenboh |
11 |
0 |
edit |
|
| Adult Health 1.1 |
Adult Health 1.1 |
Unfinished |
2025-01-31 |
Wasurenboh |
20 |
0 |
edit |
|
| Adult Health Skin |
Adult Health Skin |
Unfinished |
2025-01-31 |
Wasurenboh |
19 |
0 |
edit |
|
| Cranial Nerves |
Cranial Nerves |
Unfinished |
2025-02-07 |
Wasurenboh |
12 |
0 |
edit |
|
| Test 2 |
Lung sounds |
Unfinished |
2025-02-08 |
Wasurenboh |
16 |
0 |
edit |
|
| Test 3&4 Jarvis |
Test 3&4 Jarvis |
Unfinished |
2025-03-05 |
Wasurenboh |
18 |
0 |
edit |
|
| Jarvis Final Pt 2 |
Jarvis Final Pt 2 |
Unfinished |
2025-02-20 |
Wasurenboh |
11 |
0 |
edit |
|
| Important Hormones |
Important Hormones |
Unfinished |
2025-03-02 |
Wasurenboh |
12 |
0 |
edit |
|
| Drugs for Test 2 |
Drugs for Test 2 |
Unfinished |
2025-03-02 |
Wasurenboh |
21 |
0 |
edit |
|
| Pharm Test 3.1 |
Pharm Test 3.1 |
Unfinished |
2025-04-07 |
Wasurenboh |
19 |
0 |
edit |
|
| Pharm Test 3.2 |
Pharm Test 3.2 |
Unfinished |
2025-04-05 |
Wasurenboh |
20 |
0 |
edit |
|
| Pharm 3.3 |
Pharm 3.3 |
Unfinished |
2025-04-07 |
Wasurenboh |
11 |
0 |
edit |
|
| Glaucoma |
Glaucoma |
Unfinished |
2025-04-05 |
Wasurenboh |
14 |
0 |
edit |
|
| Macular Degen |
Macular Degeneratio |
Unfinished |
2025-04-05 |
Wasurenboh |
18 |
0 |
edit |
|
| Cataracts |
Cataracts |
Unfinished |
2025-04-05 |
Wasurenboh |
11 |
0 |
edit |
|
| External Otitis |
External Otitis |
Unfinished |
2025-04-05 |
Wasurenboh |
12 |
0 |
edit |
|
| Otitis Media |
Otitis Media |
Unfinished |
2025-04-05 |
Wasurenboh |
13 |
0 |
edit |
|
| Meniere’s Disease |
Meniere’s Disease |
Unfinished |
2025-04-05 |
Wasurenboh |
11 |
0 |
edit |
|
| HIV AIDS |
HIV AIDS |
Unfinished |
2025-04-06 |
Wasurenboh |
16 |
0 |
edit |
|
| Seizures |
Seizures |
Unfinished |
2025-04-18 |
Wasurenboh |
21 |
0 |
edit |
|
| Migranes |
Migranes |
Unfinished |
2025-04-19 |
Wasurenboh |
20 |
0 |
edit |
|
| Meningitits |
Meningitits |
Unfinished |
2025-04-19 |
Wasurenboh |
18 |
0 |
edit |
|
| Tumors |
Tumors |
Unfinished |
2025-04-19 |
Wasurenboh |
21 |
0 |
edit |
|
| Parkinson's |
Parkinson's |
Unfinished |
2025-04-19 |
Wasurenboh |
20 |
0 |
edit |
|
| Alzheimer's |
Alzheimer's |
Unfinished |
2025-04-19 |
Wasurenboh |
20 |
0 |
edit |
|
| Rheum Arthritis |
Rheum Arthritis |
Unfinished |
2025-04-26 |
Wasurenboh |
21 |
0 |
edit |
|
| Fibromyalgia |
Fibromyalgia |
Unfinished |
2025-04-19 |
Wasurenboh |
21 |
0 |
edit |
|
| SLE |
SLE |
Unfinished |
2025-04-19 |
Wasurenboh |
21 |
0 |
edit |
|
| Cancer |
Cancer |
Unfinished |
2025-04-25 |
Wasurenboh |
20 |
0 |
edit |
|
| Pregnancy Changes |
Pregnancy Changes |
Unfinished |
2025-06-27 |
Wasurenboh |
16 |
0 |
edit |
|
| Obstetrics Basics |
Obstetrics Basics |
Unfinished |
2025-06-24 |
Wasurenboh |
21 |
0 |
edit |
|
| Fetal Development |
Fetal Development |
Unfinished |
2025-06-27 |
Wasurenboh |
21 |
0 |
edit |
|
| Fetal Monitoring |
Fetal Monitoring |
Unfinished |
2025-06-29 |
Wasurenboh |
20 |
0 |
edit |
|
| Obsteric Hx & Assess |
Obsteric Hx & Assess |
Unfinished |
2025-06-29 |
Wasurenboh |
20 |
0 |
edit |
|
| Labor |
Labor |
Unfinished |
2025-06-29 |
Wasurenboh |
20 |
0 |
edit |
|
| Stages of Labor |
Stages of Labor |
Unfinished |
2025-06-29 |
Wasurenboh |
21 |
0 |
edit |
|
| Neuro Symptoms Gen |
Neuro Symptoms Gen |
Unfinished |
2025-09-25 |
Wasurenboh |
20 |
0 |
edit |
|
| MS3 Exam 2 Treatment |
MS3 Exam 2 Treatment |
Unfinished |
2025-10-10 |
Wasurenboh |
19 |
0 |
edit |
|
| Cirrhosis and Panc |
Cirrhosis and Panc |
Unfinished |
2025-10-10 |
Wasurenboh |
9 |
0 |
edit |
|
| Burns Endo Meds |
Burns Endo Meds |
Unfinished |
2025-10-22 |
Wasurenboh |
20 |
0 |
edit |
|
| Fractures |
Fractures |
Unfinished |
2025-12-15 |
Wasurenboh |
21 |
0 |
edit |
|
| Casts and Traction |
Casts and Traction |
Unfinished |
2025-12-15 |
Wasurenboh |
21 |
0 |
edit |
|
| Arthroplasties |
Arthroplasties |
Unfinished |
2025-12-15 |
Wasurenboh |
10 |
0 |
edit |
|
| Gastritis |
Gastritis |
Unfinished |
2025-12-15 |
Wasurenboh |
19 |
0 |
edit |
|
| PUD Dumping Syndrome |
PUD Dumping Syndrome |
Unfinished |
2025-12-15 |
Wasurenboh |
17 |
0 |
edit |
|
| Dermatologic Issues |
Dermatologic Issues |
Unfinished |
2025-12-15 |
Wasurenboh |
21 |
0 |
edit |
|
| Skin Disorders |
Skin Disorders |
Unfinished |
2025-12-15 |
Wasurenboh |
20 |
0 |
edit |
|
| Na+ K+ Fluid Volume |
Sodium Potassium |
Unfinished |
2025-12-15 |
Wasurenboh |
19 |
0 |
edit |
|
| Calcium Magnesium |
Calcium Magnesium |
Unfinished |
2025-12-15 |
Wasurenboh |
12 |
0 |
edit |
|
| IV Entereal PET |
IV Management |
Unfinished |
2025-12-18 |
Wasurenboh |
20 |
0 |
edit |
|
| Trach Foley Ostomy |
Trach Foley Ostomy |
Unfinished |
2025-12-15 |
Wasurenboh |
9 |
0 |
edit |
|
| Peds GI |
Peds GI |
Unfinished |
2025-12-15 |
Wasurenboh |
21 |
0 |
edit |
|
| Peds Neuro |
Peds Neuro |
Unfinished |
2025-12-18 |
Wasurenboh |
20 |
0 |
edit |
|
| Peds Respiratory |
Peds Respiratory |
Unfinished |
2025-12-18 |
Wasurenboh |
14 |
0 |
edit |
|
| Heart Failure |
Heart Failure |
Unfinished |
2025-12-15 |
Wasurenboh |
18 |
0 |
edit |
|
| Cardiac Testing |
Cardiac Testing |
Unfinished |
2025-12-15 |
Wasurenboh |
21 |
0 |
edit |
|
| EKG |
EKG |
Unfinished |
2025-12-16 |
Wasurenboh |
21 |
0 |
edit |
|